|
1
|
Gimbrone MA Jr and García-Cardeña G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Libby P, Ridker PM and Hansson GK; Leducq
Transatlantic Network on Atherothrombosis: Inflammation in
atherosclerosis: From pathophysiology to practice. J Am Coll
Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ross R: Atherosclerosis is an inflammatory
disease. Am Heart J. 138:S419–S420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Otsuka F, Finn AV, Yazdani SK, Nakano M,
Kolodgie FD and Virmani R: The importance of the endothelium in
atherothrombosis and coronary stenting. Nat Rev Cardiol. 9:439–453.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pober JS and Sessa WC: Evolving functions
of endothelial cells in inflammation. Nat Rev Immunol. 7:803–815.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rao RM, Yang L, Garcia-Cardena G and
Luscinskas FW: Endothelial-dependent mechanisms of leukocyte
recruitment to the vascular wall. Circ Res. 101:234–247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stary HC: Natural history and histological
classification of atherosclerotic lesions: An update. Arterioscler
Thromb Vasc Biol. 20:1177–1178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Virmani R, Kolodgie FD, Burke AP, Farb A
and Schwartz SM: Lessons from sudden coronary death: A
comprehensive morphological classification scheme for
atherosclerotic lesions. Arterioscler Thromb Vasc Biol.
20:1262–1275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gimbrone MA Jr: Endothelial dysfunction,
hemodynamic forces, and atherosclerosis. Thromb Haemost.
82:722–726. 1999.PubMed/NCBI
|
|
11
|
Zhang C: The role of inflammatory
cytokines in endothelial dysfunction. Basic Res Cardiol.
103:398–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pober JS, Bevilacqua MP, Mendrick DL,
Lapierre LA, Fiers W and Gimbrone MA Jr: Two distinct monokines,
interleukin 1 and tumor necrosis factor, each independently induce
biosynthesis and transient expression of the same antigen on the
surface of cultured human vascular endothelial cells. J Immunol.
136:1680–1687. 1986.PubMed/NCBI
|
|
13
|
Libby P, Ordovas JM, Auger KR, Robbins AH,
Birinyi LK and Dinarello CA: Endotoxin and tumor necrosis factor
induce interleukin-1 gene expression in adult human vascular
endothelial cells. Am J Pathol. 124:179–185. 1986.PubMed/NCBI
|
|
14
|
Tedgui A and Mallat Z: Cytokines in
atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev.
86:515–581. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tousoulis D, Oikonomou E, Economou EK,
Crea F and Kaski JC: Inflammatory cytokines in atherosclerosis:
Current therapeutic approaches. Eur Heart J. 37:1723–1732. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hochstrasser M: Origin and function of
ubiquitin-like proteins. Nature. 458:422–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kerscher O, Felberbaum R and Hochstrasser
M: Modification of proteins by ubiquitin and ubiquitin-like
proteins. Annu Rev Cell Dev Biol. 22:159–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weissman AM: Themes and variations on
ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Komatsu M, Chiba T, Tatsumi K, Iemura S,
Tanida I, Okazaki N, Ueno T, Kominami E, Natsume T and Tanaka K: A
novel protein-conjugating system for Ufm1, a ubiquitin-fold
modifier. EMBO J. 23:1977–1986. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang SH, Kim GR, Seong M, Baek SH, Seol
JH, Bang OS, Ovaa H, Tatsumi K, Komatsu M, Tanaka K, et al: Two
novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1
and UfSP2. J Biol Chem. 282:5256–5262. 2007. View Article : Google Scholar
|
|
21
|
Daniel J and Liebau E: The ufm1 cascade.
Cells. 3:627–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tatsumi K, Sou YS, Tada N, Nakamura E,
Iemura S, Natsume T, Kang SH, Chung CH, Kasahara M, Kominami E, et
al: A novel type of E3 ligase for the Ufm1 conjugation system. J
Biol Chem. 285:5417–5427. 2010. View Article : Google Scholar :
|
|
23
|
Shiwaku H, Yoshimura N, Tamura T, Sone M,
Ogishima S, Watase K, Tagawa K and Okazawa H: Suppression of the
novel ER protein Maxer by mutant ataxin-1 in Bergman glia
contributes to non-cell-autonomous toxicity. EMBO J. 29:2446–2460.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoo HM, Kang SH, Kim JY, Lee JE, Seong MW,
Lee SW, Ka SH, Sou YS, Komatsu M, Tanaka K, et al: Modification of
ASC1 by UFM1 is crucial for ERα transactivation and breast cancer
development. Mol Cell. 56:261–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim CH, Nam HS, Lee EH, Han SH, Cho HJ,
Chung HJ, Lee NS, Choi SJ, Kim H, Ryu JS, et al: Overexpression of
a novel regulator of p120 catenin, NLBP, promotes lung
adenocarcinoma proliferation. Cell Cycle. 12:2443–2453. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azfer A, Niu J, Rogers LM, Adamski FM and
Kolattukudy PE: Activation of endoplasmic reticulum stress response
during the development of ischemic heart disease. Am J Physiol
Heart Circ Physiol. 291:H1411–H1420. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lemaire K, Moura RF, Granvik M,
Igoillo-Esteve M, Hohmeier HE, Hendrickx N, Newgard CB, Waelkens E,
Cnop M and Schuit F: Ubiquitin fold modifier 1 (UFM1) and its
target UFBP1 protect pancreatic beta cells from ER stress-induced
apoptosis. PLoS One. 6:e185172011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu X, Pang Q, Shen Q, Liu H, He J, Wang J,
Xiong J, Zhang H and Chen F: Ubiquitin-fold modifier 1 inhibits
apoptosis by suppressing the endoplasmic reticulum stress response
in Raw264.7 cells. Int J Mol Med. 33:1539–1546. 2014.PubMed/NCBI
|
|
29
|
Zhang Y, Zhang M, Wu J, Lei G and Li H:
Transcriptional regulation of the Ufm1 conjugation system in
response to disturbance of the endoplasmic reticulum homeostasis
and inhibition of vesicle trafficking. PLoS One. 7:e485872012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh J, Riek AE, Weng S, Petty M, Kim D,
Colonna M, Cella M and Bernal-Mizrachi C: Endoplasmic reticulum
stress controls M2 macrophage differentiation and foam cell
formation. J Biol Chem. 287:11629–11641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tabas I: The role of endoplasmic reticulum
stress in the progression of atherosclerosis. Circ Res.
107:839–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tabas I: Macrophage apoptosis in
atherosclerosis: Consequences on plaque progression and the role of
endoplasmic reticulum stress. Antioxid Redox Signal. 11:2333–2339.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pang Q, Xiong J, Hu XL, He JP, Liu HF,
Zhang GY, Li YY and Chen FL: UFM1 Protects macrophages from
oxLDL-induced foam cell formation through a liver X receptor α
dependent pathway. J Atheroscler Thromb. 22:1124–1140. 2015.
View Article : Google Scholar
|
|
34
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu H, Yang Y, Allister EM, Wijesekara N
and Wheeler MB: The identification of potential factors associated
with the development of type 2 diabetes: A quantitative proteomics
approach. Mol Cell Proteomics. 7:1434–1451. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang B, Chen H and Fan M: Inhibition of
TLR4 signaling pathway: Molecular treatment strategy of
periodontitis-associated atherosclerosis. Med Hypotheses.
70:614–617. 2008. View Article : Google Scholar
|
|
37
|
Lin MI and Sessa WC: Vascular endothelial
growth factor signaling to endothelial nitric oxide synthase: More
than a FLeeTing moment. Circ Res. 99:666–668. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stoll LL, Denning GM and Weintraub L:
Potential role of endotoxin as a proinflammatory mediator of
atherosclerosis. Arterioscler Thromb Vasc Biol. 24:2227–2236. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sen R and Baltimore D: Inducibility of
kappa immunoglobulin enhancer-binding protein Nf-kappa B by a
posttranslational mechanism. Cell. 47:921–928. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fitzgerald KA and Chen ZJ: Sorting out
Toll signals. Cell. 125:834–836. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li H and Sun B: Toll-like receptor 4 in
atherosclerosis. J Cell Mol Med. 11:88–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rakonczay Z Jr, Hegyi P, Takács T,
McCarroll J and Saluja AK: The role of NF-kappaB activation in the
pathogenesis of acute pancreatitis. Gut. 57:259–267. 2008.
View Article : Google Scholar
|
|
45
|
Gusarova GA, Wang IC, Major ML,
Kalinichenko VV, Ackerson T, Petrovic V and Costa RH: A
cell-penetrating ARF peptide inhibitor of FoxM1 in mouse
hepatocellular carcinoma treatment. J Clin Invest. 117:99–111.
2007. View Article : Google Scholar
|
|
46
|
Xi P, Ding D, Zhou J, Wang M and Cong YS:
DDRGK1 regulates NF-κB activity by modulating IκBα stability. PLoS
One. 8:e642312013. View Article : Google Scholar
|
